|
Volumn 9, Issue 6, 2012, Pages 309-310
|
Targeted therapies: Manufacturer sponsorship bias in economic analyses matters
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CONFLICT OF INTEREST;
DRUG COST;
DRUG INDUSTRY;
ECONOMIC EVALUATION;
FUNDING;
HEALTH ECONOMICS;
MOLECULARLY TARGETED THERAPY;
PRIORITY JOURNAL;
PUBLISHING;
REVIEW;
BIAS (EPIDEMIOLOGY);
CONFLICT OF INTEREST;
DISCLOSURE;
DRUG INDUSTRY;
HUMANS;
MOLECULAR TARGETED THERAPY;
RESEARCH SUPPORT AS TOPIC;
|
EID: 84861761180
PISSN: 17594774
EISSN: 17594782
Source Type: Journal
DOI: 10.1038/nrclinonc.2012.75 Document Type: Review |
Times cited : (1)
|
References (8)
|